If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSO4.L Regulatory News (SO4)

  • There is currently no data for SO4

Funding Update

27 Nov 2020 15:39

RNS Number : 8117G
Salt Lake Potash Limited
27 November 2020
 

27 November 2020

 

AIM/ASX Code: SO4

 

 

SALT LAKE POTASH LIMITED

Funding Update

 

 

Further to its announcement of a trading halt on the Australian Securities Exchange (ASX) earlier today, Salt Lake Potash Limited ("Company") advises that it is substantially advanced in satisfying the remaining conditions precedent to enable draw down of the debt financing ("Main Facility") as announced on 5 August 2020. It is expected that a further equity fundraising will be required to satisfy the cost to complete condition and enable drawdown. The details of the fundraising are currently being finalised and a further announcement will be made as appropriate. The Company anticipates that the bridge facility will be extended beyond the end of November and repaid from proceeds of the Main Facility upon initial drawdown.

Completion of the fundraising will enable the Company to deliver the Lake Way Project on schedule, with first Sulphate of Potash (SOP) production expected as previously announced, in the March quarter 2021.

For further information please visit www.so4.com.au or contact:

 

Tony Swiericzuk / Richard Knights

Salt Lake Potash Limited

Tel: +61 8 6559 5800

Colin Aaronson / Seamus Fricker

Grant Thornton UK LLP (Nominated Adviser)

Tel: +44 (0) 20 7383 5100

Derrick Lee / Peter Lynch

Cenkos Securities plc (Joint Broker)

Tel: +44 (0) 131 220 6939

Rupert Fane / Ernest Bell

Hannam & Partners (Joint Broker)

Tel: +44 (0) 20 7907 8500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVELRLDFII
Date   Source Headline
5th Apr 20127:00 amRNSPlacing of up to £5.56 million to initiate BFS
28th Mar 20127:00 amRNSPositive Resource Update and Results of PFS
19th Mar 20127:00 amRNSIndependent Engineer's Review, Mecsek Hills UCG
15th Mar 20127:00 amRNSInterim Results
16th Feb 20127:00 amRNSCo-operation Agreement re Uranium Licences
31st Jan 20127:00 amRNSDecember 2011 Quarterly Report
29th Nov 20117:00 amRNSCorporate Presentation
28th Nov 20119:45 amRNSBroadcast with Liberum Analyst
24th Nov 20117:00 amRNSResults of AGM
31st Oct 20117:00 amRNSChairman's Statement & Review of Operations
27th Oct 20117:45 amRNSSeptember Quarterly Report
24th Oct 20117:00 amRNSNotice of AGM
30th Sep 201112:33 pmRNSFinancial Report
30th Aug 20117:00 amRNSMOU with Air Liquide
9th Aug 20119:21 amRNSAppointment of New Company Secretary
3rd Aug 20117:15 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.